Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    3901 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 52
    3902 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
    3903 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 75
    3904 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 72
    3905 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 62
    3906 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 40
    3907 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 65
    3908 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 67
    3909 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 72
    3910 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 64
    3911 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 64
    3912 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 53
    3913 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 53
    3914 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 73
    3915 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
    3916 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 8
    3917 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 66
    3918 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 26
    3919 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 56
    3920 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 63
    3921 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 61
    3922 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
    3923 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 66
    3924 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Germany 48
    3925 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Germany 58
    3926 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Germany 59
    3927 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 62
    3928 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 63
    3929 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 64
    3930 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 66
    3931 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 65
    3932 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 56
    3933 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 75
    3934 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 65
    3935 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 51
    3936 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 63
    3937 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 75
    3938 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 64
    3939 Apheresis Allogeneic Myeloma Multiplex Hematology 2021 Standard Therapy Poland 48
    3940 Apheresis Allogeneic Myeloma Multiplex Hematology 2021 Standard Therapy Poland 53
    3941 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2021 Standard Therapy Poland 67
    3942 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2021 Standard Therapy Poland 58
    3943 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2021 Standard Therapy Germany 51
    3944 Apheresis Allogeneic No Data Hematology 2021 Standard Therapy Poland 64
    3945 Apheresis Allogeneic No Data Hematology 2021 Standard Therapy Poland 57
    3946 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 30
    3947 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 51
    3948 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 58
    3949 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 56
    3950 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 58
    3951 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 50
    3952 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 53
    3953 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 20
    3954 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 64
    3955 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 66
    3956 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 62
    3957 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 61
    3958 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 49
    3959 Apheresis Allogeneic Non-Hodgkin-Lymphoma-Relapse Hematology 2021 Standard Therapy Germany 62
    3960 Apheresis Allogeneic Osteomyelitis Hematology 2021 Standard Therapy Poland 47
    3961 Apheresis Allogeneic Osteomyelofibrosis Hematology 2021 Standard Therapy Poland 69
    3962 Apheresis Allogeneic Osteomyelofibrosis Hematology 2021 Standard Therapy Poland 43
    3963 Apheresis Autologous Osteosclerotic Myeloma Hematology 2021 Standard Therapy Germany 54
    3964 Apheresis Allogeneic Other Myelodysplastic Syndromes Hematology 2021 Standard Therapy Poland 65
    3965 Apheresis Allogeneic Other Myelofibrosis Hematology 2021 Standard Therapy Poland 68
    3966 Apheresis Allogeneic Other Myelofibrosis Hematology 2021 Standard Therapy Poland 70
    3967 Apheresis Allogeneic Other Myelofibrosis Hematology 2021 Standard Therapy Poland 72
    3968 Apheresis Allogeneic Other Plasma Cell Disorder Hematology 2021 Standard Therapy Poland 67
    3969 Apheresis Allogeneic Peripheral T-Cell Lymphoma Hematology 2021 Standard Therapy Poland 45
    3970 Apheresis Allogeneic Philadelphia-Positive Acute Lymphoblastic Leukemia Hematology 2021 Standard Therapy Poland 61
    3971 Apheresis Allogeneic Polycythemia Vera Hematology 2021 Standard Therapy Poland 65
    3972 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 71
    3973 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 66
    3974 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 62
    3975 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 53
    3976 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 44
    3977 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 54
    3978 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 65
    3979 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 65
    3980 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 60
    3981 Apheresis Allogeneic Primary Myelofibrosis Hematology 2021 Standard Therapy Poland 66
    3982 Apheresis Allogeneic Primary Myelofibrosis Hematology 2021 Standard Therapy Poland 63
    3983 Apheresis Allogeneic Primary Myelofibrosis Hematology 2021 Standard Therapy Poland 62
    3984 Apheresis Allogeneic Primary Myelofibrosis Hematology 2021 Standard Therapy Poland 64
    3985 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2021 Standard Therapy Poland 68
    3986 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2021 Standard Therapy Poland 64
    3987 Apheresis Allogeneic Refractory Cytopenia Hematology 2021 Standard Therapy Poland 6
    3988 Apheresis Allogeneic Secondary Acute Lymphoblastic Leukemia From Chronic Myeloid Leukemia Hematology 2021 Standard Therapy Poland 58
    3989 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 70
    3990 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 64
    3991 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 39
    3992 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 60
    3993 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2021 Standard Therapy Poland 35
    3994 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2021 Standard Therapy Poland 58
    3995 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2021 Standard Therapy Poland 41
    3996 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2021 Standard Therapy Poland 38
    3997 Apheresis Allogeneic Severe Combined Immunodeficiency Hematology 2021 Standard Therapy Poland 1
    3998 Apheresis Allogeneic Severe Combined Immunodeficiency Hematology 2021 Standard Therapy Poland 1
    3999 Apheresis Allogeneic T-Cell Lymphoblastic Lymphoma Hematology 2021 Standard Therapy Germany 26
    4000 Apheresis Allogeneic T-Cell Lymphoblastic Lymphoma Hematology 2021 Standard Therapy Germany 37